APOBEC2 and gastric adenocarcinoma: And multivariate Cox analysis demonstrated that the two-marker classifier (APOBEC2 and CD66b) couldn’t independently predict the prognosis of STAD, when the APOBEC2+CD66bhigh subgroup was used to a reference.